Capula Management’s Alpine Immune Sciences Inc ALPN Stock Holding History

Capula Management’s Portfolio ALPN Stock Details ALPN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-23,970	Closed	-$950K	–	700
2024 Q1	$950K	Buy	+23,970	New	+$707K	0.02%	98

Capula Management's ALPN Position: Q2 2024 in Review

Capula Management sold out of Alpine Immune Sciences Inc (ALPN) in Q2 2024, closing a stake of 23,970 shares — an estimated $950K sold.

Capula Management first reported a position in ALPN in Q1 2024 and held it in 1 quarter. The position peaked at $950K in Q1 2024. 0 funds tracked by Wall St. Rank hold ALPN as of Q2 2024.

Capula Management reported no remaining Alpine Immune Sciences Inc position as of Q2 2024 after selling out during the quarter.
Capula Management sold 23,970 Alpine Immune Sciences Inc shares in Q2 2024, an estimated $950K.
Capula Management first reported a position in Alpine Immune Sciences Inc in Q1 2024 and held it in 1 quarter.
Capula Management's Alpine Immune Sciences Inc position peaked at $950K in Q1 2024.
0 funds tracked by Wall St. Rank held Alpine Immune Sciences Inc as of Q2 2024.

Based on Capula Management's 13F filing for Q2 2024, filed 5 Aug 2024.